Citation Impact

Citing Papers

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
2009
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
2015
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Mammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease
2019
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Structure of the human TRPM4 ion channel in a lipid nanodisc
2017 StandoutScienceNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma
2009
Cell-free circulating tumor DNA in cancer
2016
Structure of the TRPA1 ion channel suggests regulatory mechanisms
2015 StandoutNatureNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Sensitization of TRPA1 by Protein Kinase A
2017
Irritant-evoked activation and calcium modulation of the TRPA1 receptor
2020 StandoutNatureNobel
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
TRPM8 ion channel ligands for new therapeutic applications and as probes to study menthol pharmacology
2012
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Transient receptor potential channels as therapeutic targets
2011
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Histopathologic Features of Early (Patch) Lesions of Mycosis Fungoides
2005
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Structure of the TRPV1 ion channel determined by electron cryo-microscopy
2013 StandoutNatureNobel
TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action
2016 StandoutNatureNobel
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting
2001
TRPA1 as a drug target—promise and challenges
2015
Molecular evolution of FOXP2, a gene involved in speech and language
2002 StandoutNatureNobel
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
TRP Channels and Pain
2013 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Breathtaking TRP Channels: TRPA1 and TRPV1 in Airway Chemosensation and Reflex Control
2008
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
2008
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
TRPA1: A Gatekeeper for Inflammation
2012
Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases
2008
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors
2002
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
2007
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
2013
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Structural insights into TRPM8 inhibition and desensitization
2019 StandoutScienceNobel
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout

Works of Daniela Massi being referenced

Cigarette smoke–induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents
2008
Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001
2004
Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer.
1998
Multiparametric Analysis of Cell-Free DNA in Melanoma Patients
2012
HISTOPATHOLOGIC CORRELATES OF DERMOSCOPIC CRITERIA
2001
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors
2007
Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma
2010
Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities
2013
Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients
2010
Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression
2010
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor‐C expression in head and neck squamous cell carcinoma
2005
Circulating cell-free DNA in plasma of melanoma patients: Qualitative and quantitative considerations
2011
PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
2016
Efficacy of Histologic Criteria for Diagnosing Early Mycosis Fungoides
2000
Tumor lymphangiogenesis in head and neck squamous cell carcinoma
2004
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma
2005
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
2017
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics
2014
Interactive atlas of dermoscopy
2000
Rankless by CCL
2026